Vol:25 | No:03 - DiabetesontheNet

This site is intended for healthcare professionals only

Diabetes &
Primary Care

Vol:25 | No:03

Filter:

Editorial: Let’s not underestimate the impact of lifestyle on diabetes control

Amid shortages of diabetes drugs, Jane Diggle recommends new advice from PCDS and ABCD, but also reminds us of the benefits of lifestyle intervention.

Page: 63

Joint PCDS and ABCD guidance: GLP-1 receptor agonist national shortage

Joint guidance from the PCDS and ABCD to support clinicians in selecting alternative glucose-lowering therapies when GLP-1 RAs are unavailable.

Page: 67

Using lifestyle as medicine: Setting up type 2 diabetes lifestyle clinics in West Wales

Although challenging, setting up clinics to support people in changing their diet and lifestyle has dramatic results.

Page: 69

Q&A: Diabetic retinopathy

Retinopathy pathophysiology, screening and treatment: The experts answer key questions.

Page: 73

At a glance factsheet: Deprescribing in type 2 diabetes

When and how to deprescribe non-insulin glucose-lowering therapies in a safe and patient-centred manner.

Page: 77

At a glance factsheet: Peripheral arterial disease

Diagnosis and management of PAD: The essentials for primary care.

Page: 79

Interactive case study: Erectile dysfunction in type 2 diabetes

The causes and management of erectile dysfunction in men with type 2 diabetes.

Page: 83

Conference over coffee: The importance of weight loss

Weight loss and type 2 diabetes remission: Highlights from the Diabetes UK Professional Conference 2023.

Page: 85

PCDS Committee elections (2023): Call for candidates

Applications are now open to stand for election to the PCDS Committee.

Page: 87

PCDS National Conference: Request for poster abstracts

Poster abstract submissions are invited for the 19th National Conference of the PCDS, which will be held on 13 and 14 September.

Page: 89

Diabetes Distilled: Lifestyle change for microvascular gain

Five healthy behaviours to reduce microvascular complications in people with type 2 diabetes.

Page: 91

Diabetes Distilled: Once-weekly insulins – ONWARDS and upwards?

Once-weekly insulin icodec associated with HbA1c benefits in type 2 diabetes, but is hypoglycaemia a concern?

Page: 93

Diabetes Distilled: Renoprotective benefits associated with SGLT2 inhibitor use in real-world studies

Meta-analysis suggests SGLT2 inhibitors are associated with a 46% lower risk of renal failure compared with other diabetes drugs.

Page: 95

Diabetes Distilled: Sex differences in type 2 diabetes

The key sex differences in type 2 diabetes diagnosis, complications, mortality and treatment.

Page: 97

LATEST ARTICLES

Interactive case study: Managing acute illness in type 2 diabetes

Diabetes Distilled: ABCD–UKKA concise recommendations for management of CKD in type 2 diabetes

Welcome to the new PCDS Chair and Secretary

Conference over coffee: Diabetes and obesity initiatives, multiple long-term condition management and the bookends of pregnancy

Scottish Government and NHS Scotland consensus statement on GLP-1-based therapies for obesity

Editorial: Type 2 diabetes, CVD, CKD, dementia and health inequality: Adopting a preventative approach

The dialysis timebomb: Why preventing kidney disease is everyone’s responsibility

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;